Jeffrey Wagner, MD
Allergy & Immunology · Spartanburg, SCNPI 1881684207
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,082 of the $6,966 with a category attached, or 87.3%. 22 manufacturers reported payments, led by AstraZeneca at 33.3% of the total. Reporting peaked in 2020 at $1,450 and has fallen 75.9% since, to $350 in 2025. That places this record below the midpoint for allergy & immunology clinicians in SC, where the typical reported total is $7,297.
Across 224 payments — averaging $31.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Sanofi$1K
- Biocryst Pharmaceuticals, Inc.$897
- GSK$675
- AbbVie$252
- Biocryst US Sales Co., LLC$244
- plus $1K from 16 others
What the payments were for
- Consulting fees$87513%
- Food & beverage$6,08287%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 42 | $2,323 |
| Sanofi | 82 | $1,158 |
| Biocryst Pharmaceuticals, Inc. | 2 | $897 |
| GSK | 30 | $675 |
| AbbVie | 6 | $252 |
| Biocryst US Sales Co., LLC | 11 | $244 |
| CSL Behring | 5 | $224 |
| Alk-abello, Inc | 9 | $209 |
| Amgen(2 entities) | 8 | $207 |
| Teva Pharmaceuticals USA, Inc. | 5 | $144 |
| Regeneron Healthcare Solutions, Inc. | 3 | $116 |
| Pfizer | 3 | $93 |
| Phathom Pharmaceuticals, Inc. | 1 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| Novartis | 2 | $66 |
| Optinose US, Inc. | 4 | $62 |
| Incyte Corporation | 2 | $47 |
| Kaleo, Inc. | 2 | $38 |
| Verona Pharma, Inc. | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Mylan Specialty L.p. | 1 | $13 |
| Shire North American Group Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FASENRA$471
- TEZSPIRE$339
- TRELEGY ELLIPTA$226
- BREZTRI AEROSPHERE$134
- BREZTRI$122
- Rinvoq$119
- SYMBICORT$109
- Haegarda$108
- AirDuo RespiClick$103
- ArmonAir Digihaler$103
- ProAir Digihaler$103
How this compares
$6,966 in reported general payments places this provider in the 45th percentile of 46 allergy & immunology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 32 | $147,172 |
| TezspireTezepelumab-Ekko | 14 | $63,393 |
| XolairOmalizumab | 11 | $57,234 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 32 | $27,347 |
| Breo ElliptaFluticasone/Vilanterol | 43 | $20,505 |
| SymbicortBudesonide/Formoterol Fumarate | 31 | $9,818 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $7,924 |
| Pulmicort FlexhalerBudesonide | 18 | $6,685 |
| Arnuity ElliptaFluticasone Furoate | 21 | $6,670 |
| Epinephrine | 37 | $6,056 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 16 | $3,550 |
| Wixela InhubFluticasone Propion/Salmeterol | 18 | $2,847 |
| Montelukast Sodium | 297 | $2,604 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $2,596 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 77 | $2,564 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaTezspire, Symbicort, Breztri Aerosphere, Pulmicort Flexhaler | $2,323 | $87,82076 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $675 | $54,52296 claims |
| Hikma Pharmaceuticals USAEpinephrine | $15 | $6,05637 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 46 allergy & immunology providers in South Carolina.
Other allergy & immunology in Spartanburg
- Jaime LagosSpartanburg$54K
- Robin GoSpartanburg$14K
- Thomas MurphyCharleston$653K
- Douglas JohnstonGreenville$329K
- Allen KaplanNorth Charleston$220K
- David AmrolColumbia$172K
- Ned RuppNorth Charleston$154K
- John RameyNorth Charleston$126K
- Patricia GerberNorth Charleston$17K
- Hector RodriguezWest Columbia$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.